3 ASX shares that turned $100,000 into $1 million in 10 years or less

Choose quality stocks representing companies with rapidly growing market share, and your millionaire dreams could come true.

Forget artificial intelligence, cryptocurrencies and 3D printing.

You don't need to jump on the latest fad to rake in amazing returns from ASX shares.

Just pick out quality businesses with unique products or services, and you could turn $100,000 into $1 million in only 10 years. Maybe you don't even have to wait a full decade.

You don't believe me?

Here are three examples playing in very different realms that have made their investors filthy rich:

A young well-dressed couple at a luxury resort celebrate successful life choices.

Image source: Getty Images

1. Global leader of what humankind depends on now

Altium Limited (ASX: ALU) is an Australian-founded company that makes electronic design software.

Specifically, it helps engineers design printed circuit boards, which are the basic building blocks of modern computers.

Solaris Investment Management chief investment officer Michael Bell is a fan of the business, describing it as "strong leaders in their industry with strong pricing power".

And he loves that Altium displays what his team calls strong "earnings quality", which is not using accounting loopholes to make the EBITDA look better than it really is.

"They expense capex. That is really important to see that. That gives us confidence to invest in these companies."

So, what would have happened if you bought $100,000 worth of Altium shares on 20 September 2013?

You will have more than $1.7 million now.

2. Investing for growth without any debt

While Pro Medicus Limited (ASX: PME) also makes software, its clientele is completely different to Altium.

The Melbourne company supplies imaging tools for hospitals and clinics, and has been doing this since the 1980s.

The Motley Fool's Tristan Harrison this month pointed out a massive pro for Pro Medicus, considering it's a business that's been growing so rapidly.

"The ASX 200 [company] is expanding in North America and Europe and is investing for growth," he said.

"It finished FY23 with $121.5 million of cash and other financial assets while remaining debt free."

Pro Medicus shares always seem to be derided as "expensive" by its critics. But that hasn't stopped investors making a ton of money over the years. 

Say you bought a $100,000 batch of Pro Medicus shares 10 years ago. 

What would it be worth now? Are you sitting down?

That investment would now be $16.17 million.

3. Retire now

Moving away from technology, let's take a look at a stock from a definitely old-world industry.

We know now that lithium, as an important battery ingredient, is all the rage for a net zero future.

But if you had the nous to realise this a few years ago, you could have made an outrageous return from Liontown Resources Ltd (ASX: LTR) shares.

On 19 September 2013, the stock price sat at just 1 cent as the company explored for opportunities.

Now the Liontown share price is hovering at the $3 mark, meaning $100,000 put in 10 years ago would be worth $30 million.

In fact, there is one particular investor that largely used Liontown shares to turn $156,000 into $58 million over just the past five years.

The lithium producer is now the subject of a takeover proposal from US giant Albemarle Corporation (NYSE: ALB).

More on Opinions

Senior man looking at his laptop and pondering something.
Opinions

BHP shares: I investigated the bull and the bear case, and here's where I landed

BHP shares have been relatively stable over the past six months.

Read more »

Smiling woman holding Australian dollar notes in each hand, symbolising dividends.
Opinions

Why I'd buy this ASX share over a term deposit

A few ASX shares can provide resilience, dividends, and growth.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Opinions

2 ASX shares where broker forecasts caught my attention

These two ASX shares deserve a closer look.

Read more »

Woman with her hands out to each side on a light blue background.
Opinions

I compared dividends, earnings, and growth across the ASX: These 3 shares stood out

These ASX shares caught my attention. Here’s why.

Read more »

A businessman holding a butterfly net looks around hoping to snare a good ASX share investment.
Opinions

I hunted the ASX for oversold shares. These 3 stood out

These ASX shares look oversold and under priced to me.

Read more »

Family smile and laugh as they look at a laptop.
Opinions

I've been looking for long-term ASX investments for my kids. These 4 made my shortlist

When I'm investing for my kids' futures, these are the criteria I'm looking for.

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Opinions

CSL shares: I weighed up the bull and bear case, and here's my final verdict

The ASX biotech company has rebounded strongly from a multi-year low in June.

Read more »

A young woman sitting in a classroom smiles as she ponders lessons learned.
Opinions

I looked at the bear case for these 3 ASX shares, and came to a different conclusion. Here's why

Here’s my take on these three ASX shares.

Read more »